Skip to main content
Log in

Characterization of Poly(glycolide-co-D,L-lactide)/Poly(D,L-lactide) Microspheres for Controlled Release of GM-CSF

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. This study describes the preparation and characterization of a controlled release formulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) encapsulated in poly(glycolide-co-D,L-lactide) (PLGA) and poly(D,L-lactide) (PLA) microspheres.

Methods. GM-CSF was encapsulated in PLGA/PLA microspheres by a novel silicone oil based phase separation process. Several different blends of PLGA and low molecular weight PLA were used to prepare the microspheres. The microspheres and the encapsulated GM-CSF were extensively characterized both in vitroand in vivo.

Results. Steady release of GM-CSF was achieved over a period of about one week without significant 'burst' of protein from the microspheres. Analysis of microsphere degradation kinetics by gel permeation chromatography (GPC) indicated that low molecular weight PLA enhanced the degradation of the PLGA and thereby affected release kinetics. GM-CSF released from the microspheres was found to be biologically active and physically intact by bioassay and chromato-graphic analysis. Analysis of serum from mice receiving huGM-CSF indicated that the GM-CSF was biologically active and that a concentration of greater than 10 ng/mL was maintained for a period lasting at least nine days. MuGM-CSF was not detected followingin vivo administration of muGM-CSF microspheres. The tissues of mice receiving muGM-CSF microspheres were characterized by infiltration of neutrophils, and macrophages which were in significant excess of those found in mice administered with placebo controls (i.e. microspheres without GM-CSF).

Conclusions. This study demonstrates the influence of formulation parameters on the encapsulation of GM-CSF in PLGA/PLA microspheres and its controlled release in biologically active form. The intense local tissue reaction in mice to muGM-CSF microspheres demonstrates the importance of the mode of delivery on the pharmacologic activity of GM-CSF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. M. Gough, J. Gough, D. Metcalf, A. Kelson, D. Grail, N. A. Nicola, A. W. Burgess, and A. R. Dunn. Nature, 309:763-767 (1984).

    PubMed  Google Scholar 

  2. M. A. Cantrell, D. Anderson, D. P. Cerretti, V. Price, K. McKereghan, R. J. Tushinski, D. Y. Mochizuki, A. Larsen, K. Grabstein, S. Gillis, and D. Cosman. Proc. Natl. Acad. Sci. USA, 82:6250-6254 (1985).

    PubMed  Google Scholar 

  3. P. J. Morrissey, K. H. Grabstein, S. G. Reed, and P. J. Conlon. Int. Arch. Allergy Appl. Immunol., 88:40-45 (1989).

    PubMed  Google Scholar 

  4. P. J. Morrissey, L. Bressler, L. S. Park, A. Alpert, and S. Gillis. J. Immunol., 139:1113-1119 (1987).

    PubMed  Google Scholar 

  5. S. J. Brandt, W. P. Peters, S. K. Atwater, J. Kurtzberg, M. J. Borowitz, R. B. Jones, E. J. Shpall, R. C. Bast, C. J. Gilbert, and D. H. Oette. N. Engl. J. Med., 318:869-874 (1988).

    PubMed  Google Scholar 

  6. A. D. K. Hill, H. A. Naama, S. E. Calvano, and J. M. Daly. J. Leukoc. Biol., 58:634-642 (1995).

    PubMed  Google Scholar 

  7. G. Dranoff, E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. C. Mulligan. Proc. Natl. Acad. Sci. USA, 90:3539-3543 (1993).

    PubMed  Google Scholar 

  8. D. Hovgaard, B. T. Mortensen, S. Schifter, and N. I. Nissen. Eur. J. Clin. Invest., 22:45-49 (1992).

    PubMed  Google Scholar 

  9. F. Malik, C. Delgado, C. Knüsli, A. E. Irvine, D. Fisher, and G. E. Francis. Exp. Hematol., 20:1028-1035 (1992).

    PubMed  Google Scholar 

  10. P. T. Golumbek, R. Azhari, E. M. Jaffee, H. I. Levitsky, A. Lazenby, K. Leong, and D. M. Pardoll. Cancer Res., 53:5841-5844 (1993).

    PubMed  Google Scholar 

  11. P. M. Anderson, D. C. Hanson, D. E. Hasz, M. R. Halet, B. R. Blazar, and A. C. Ochoa. Cytokine, 6:92-101 (1994).

    PubMed  Google Scholar 

  12. W. R. Gombotz, and D. K. Pettit. Bioconjugate Chem., 6:332-351 (1995).

    Google Scholar 

  13. Y. Ogawa, H. Okada, M. Yamamoto, and T. Shimamoto. Chem. Pharm. Bull., 36:2576-2588 (1988).

    PubMed  Google Scholar 

  14. O. L. Johnson, J. L. Cleland, H. J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A. J. S. Jones, and S. D. Putney. Nature Med., 2:795-799 (1996).

    PubMed  Google Scholar 

  15. W. Lu, and T. G. Park. PDA J. Pharm. Sci. and Tech., 49:13-19 (1995).

    Google Scholar 

  16. R. E. Johnson, L. A. Lanaski, V. Gupta, M. J. Griffin, H. T. Gaud, T. E. Needham, and H. Zia. J. Control. Release, 17:61-68 (1991).

    Google Scholar 

  17. M. J. Alonso, R. K. Gupta, C. Min, G. R. Siber, and R. Langer. Vaccine, 12:299-306 (1994).

    PubMed  Google Scholar 

  18. T. E. Greenway, J. H. Eldridge, G. Ludwig, J. K. Staas, J. F. Smith, R. M. Gilley, and S. M. Michalek. Vaccine, 13:1411-1420 (1995).

    PubMed  Google Scholar 

  19. T. G. Park, W. Lu, and G. Crotts. J. Control. Release, 33:211-222 (1995).

    Google Scholar 

  20. K. Yamaguchi, and J. M. Anderson. J. Control. Release, 24:81-93 (1993).

    Google Scholar 

  21. Y. Tabata, and Y. Ikada. Biomaterials, 9:356-362 (1988).

    PubMed  Google Scholar 

  22. S. C. Lee, M. Shea, M. A. Battle, K. Kozitza, E. Ron, T. Turek, R. G. Schaub, and W. C. Hayes. J. Biomed. Mater. Res., 28:1149-1156 (1994).

    PubMed  Google Scholar 

  23. S. Gillis, D. L. Urdal, W. Clevenger, R. Klinke, H. Sassenfeld, V. Price, and D. Cosman. Behring Inst. Mitt., 83:1-7 (1988).

    Google Scholar 

  24. V. Price, D. Mochizuki, C. J. March, D. Cosman, M. C. Deeley, R. Klinke, W. Clevenger, S. Gillis, P. Baker, and D. Urdal. Gene, 55:287-293 (1987).

    PubMed  Google Scholar 

  25. J. R. Lawter, and M. G. Lanzilotti. U.S. Patent #5, 143, 661, (1992).

  26. J. R. Lawter, N. S. Brizzolara, M. G. Lanzilotti, and G. M. Morton. Proceed. Intern. Symp. Control. Rel. Bioact. Materials, 14:99-100, (1987).

    Google Scholar 

  27. T. Kitamura, T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y. F. Piao, K. Miyazono, A. Urabe, and F. Takaku. J. Cell. Physiol., 140:323-334, (1989).

    PubMed  Google Scholar 

  28. T. M. Dexter, J. Garland, D. Scott, E. Scolnick, and D. Metcalf. J. Exp. Medicine, 152:1036-1047 (1980).

    Google Scholar 

  29. L. S. Park, S. Gillis, and D. L. Urdal. In G. Goldstein, J. F. Bach and H. Wigzell (eds.), Immune Regulation by Characterized Polypeptides, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 41, Alan R. Liss, Inc., 1987, pp. 443-452.

  30. R. Bodmeier, K. H. Oh, and H. Chen. Int. J. Pharm., 51:1-8 (1989).

    Google Scholar 

  31. H-K Sah, Toddywala, R., and Chien, Y. W. J. Control. Release, 30:201-211 (1994).

    Google Scholar 

  32. C. Grandfils, P. Flandroy, and R. Jerome. J. Control. Release, 38:109-122 (1996).

    Google Scholar 

  33. A. F. Lopez, N. A. Nicola, D. R. Burgess, D. Metcalf, F. L. Battye, W. A. Sewell, and M. Vadas. J. Immunol., 131:2983-2988 (1983).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dean K. Pettit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pettit, D.K., Lawter, J.R., Huang, W.J. et al. Characterization of Poly(glycolide-co-D,L-lactide)/Poly(D,L-lactide) Microspheres for Controlled Release of GM-CSF. Pharm Res 14, 1422–1430 (1997). https://doi.org/10.1023/A:1012176823155

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012176823155

Navigation